Elizabeth Faust
Förmögenhet: - $ per 2026-06-30
Förmögenhet: - $ per 2026-06-30
Elizabeth A. Faust is currently Independent Director at Biomea Fusion, Inc. since 2022 and Principal & Owner at Faust Consulting LLC since 2018.
Former roles include Executive Director-Regional Medical Liaisons at Amgen, Inc., Senior Director-Medical Affairs at Gloucester Pharmaceuticals, Inc. from 2008 to 2010, Vice President-Medical Affairs at Pharmacyclics LLC from 2013 to 2015, Executive Vice President-Medical Affairs at Tricida, Inc. from 2019 to 2020, Vice President-Clinical Research Sciences at Celgene Corp., Vice President-Medical Affairs at Kite Pharma, Inc. from 2016 to 2018, and Vice President-Medical Affairs at Pharmacyclics, Inc. from 2013 to 2015.
Education includes a doctorate from the University of California, Los Angeles, graduate studies at the University of California, Riverside, and undergraduate studies at Auburn University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
BIOMEA FUSION INC -.--% | 2026-06-10 | 0 ( -.--% ) | - $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| BIOMEA FUSION, INC. | Direktör/Styrelseledamot | 2022-06-01 |
| Företag | Position | Slut |
|---|---|---|
| TRICIDA, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2020-08-01 |
| CELGENE | Teknisk/Vetenskaplig/F&U Direktör | 2019-11-01 |
| KITE PHARMA INC | Teknisk/Vetenskaplig/F&U Direktör | 2018-07-01 |
| PHARMACYCLICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2015-11-01 |
Pharmacyclics, Inc.
Pharmacyclics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat cancer | Teknisk/Vetenskaplig/F&U Direktör | 2015-11-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 11 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Pharmacyclics LLC
Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
Gloucester Pharmaceuticals, Inc.
Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops products for the treatment of cancer patients | Health Technology |
Tricida, Inc.
Tricida, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparation products | Health Technology |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Auburn University
Auburn University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Riverside
University of California, Riverside Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kite Pharma, Inc.
Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Biomea Fusion, Inc.
Biomea Fusion, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which engages in the discovery, development and commercialization of small molecules to treat patients with genetically defined cancers | Health Technology |
Pharmacyclics, Inc.
Pharmacyclics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat cancer | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån